Shopping Cart
Total:

$0.00

Items:

0

Checkout View Cart
Your cart is empty
Keep Shopping

Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap



(MedPage Today) — Investigational apitegromab — a selective myostatin activation inhibitor — effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight “Ozempic…



Source link

0
Show Comments (0) Hide Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments